Search research articles
Contact Us
Filters
Showing results (21-30 of 166) with videos related to
Page
of 17
Sort By:
Current Oncology Reports
|
October 15, 2017
The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope
Roman Groisberg, Jason Roszik, Anthony Conley, et al.
Cancer Research
|
February 26, 2020
Targeting the SAGA and ATAC Transcriptional Coactivator Complexes in MYC-Driven Cancers
Lisa Maria Mustachio, Jason Roszik, Aimee Farria, et al.
Journal of Visualized Experiments : Jove
|
February 15, 2013
Quantitative high-throughput single-cell cytotoxicity assay for T cells
Ivan Liadi, Jason Roszik, Gabrielle Romain, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
April 2, 2023
Vestigial-like 1 (VGLL1): An ancient co-transcriptional activator linking wing, placenta, and tumor development
Heather M Sonnemann, Barbara Pazdrak, Dinler A Antunes, et al.
American Journal of Cancer Research
|
September 10, 2019
Repression of GCN5 expression or activity attenuates c-MYC expression in non-small cell lung cancer
Lisa Maria Mustachio, Jason Roszik, Aimee T Farria, et al.
JCO Precision Oncology
|
August 28, 2018
Analysis of <i>MDM2</i> Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies
Shumei Kato, Jeffrey S Ross, Laurie Gay, et al.
Current Problems in Cancer
|
October 28, 2021
<sup>18</sup>F-sodium fluoride positron emission tomography (NaF-18-PET/CT) radiomic signatures to evaluate responses to alpha-particle Radium-223 dichloride therapy in osteosarcoma metastases
Kalevi Kairemo, Jason Roszik, Pete Anderson, et al.
JAMA Network Open
|
July 16, 2021
Association of Edmonton Symptom Assessment System Global Distress Score With Overall Survival in Patients With Advanced Cancer
Ishwaria M Subbiah, Maira M Charone, Jason Roszik, et al.
Molecular Cancer Therapeutics
|
April 12, 2022
Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600-Mutant Tumors
Jacob J Adashek, Arjun K Menta, Neha K Reddy, et al.
Cancer Research
|
January 19, 2018
Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target
Lisa Maria Mustachio, Yun Lu, Masanori Kawakami, et al.
Page
of 17
Search research articles
Search
Showing results (21-30 of 166) with videos related to
Sort By:
Page
of 17
Current Oncology Reports
|
October 15, 2017
The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope
Roman Groisberg, Jason Roszik, Anthony Conley, et al.
Cancer Research
|
February 26, 2020
Targeting the SAGA and ATAC Transcriptional Coactivator Complexes in MYC-Driven Cancers
Lisa Maria Mustachio, Jason Roszik, Aimee Farria, et al.
Journal of Visualized Experiments : Jove
|
February 15, 2013
Quantitative high-throughput single-cell cytotoxicity assay for T cells
Ivan Liadi, Jason Roszik, Gabrielle Romain, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
April 2, 2023
Vestigial-like 1 (VGLL1): An ancient co-transcriptional activator linking wing, placenta, and tumor development
Heather M Sonnemann, Barbara Pazdrak, Dinler A Antunes, et al.
American Journal of Cancer Research
|
September 10, 2019
Repression of GCN5 expression or activity attenuates c-MYC expression in non-small cell lung cancer
Lisa Maria Mustachio, Jason Roszik, Aimee T Farria, et al.
JCO Precision Oncology
|
August 28, 2018
Analysis of <i>MDM2</i> Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies
Shumei Kato, Jeffrey S Ross, Laurie Gay, et al.
Current Problems in Cancer
|
October 28, 2021
<sup>18</sup>F-sodium fluoride positron emission tomography (NaF-18-PET/CT) radiomic signatures to evaluate responses to alpha-particle Radium-223 dichloride therapy in osteosarcoma metastases
Kalevi Kairemo, Jason Roszik, Pete Anderson, et al.
JAMA Network Open
|
July 16, 2021
Association of Edmonton Symptom Assessment System Global Distress Score With Overall Survival in Patients With Advanced Cancer
Ishwaria M Subbiah, Maira M Charone, Jason Roszik, et al.
Molecular Cancer Therapeutics
|
April 12, 2022
Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600-Mutant Tumors
Jacob J Adashek, Arjun K Menta, Neha K Reddy, et al.
Cancer Research
|
January 19, 2018
Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target
Lisa Maria Mustachio, Yun Lu, Masanori Kawakami, et al.
Page
of 17